Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples